惠普森医药(CPHI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CPHI 惠普森医药

盘前交易 01-14 08:06:47 EST

1.34

+0.04

+3.08%

最高1.36	最低1.30	成交量8,919
今开1.32	昨收1.30	日振幅4.31%
总市值672.95万	流通市值353.83万	总股本502.20万
成交额1.19万	换手率0.34%	流通股本264.05万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CPHI","market":"US","secType":"STK","nameCN":"惠普森医药","latestPrice":1.34,"timestamp":1768338000000,"preClose":1.3,"halted":0,"volume":8919,"delay":0,"floatShares":2640500,"shares":5022002,"eps":-1.003723,"marketStatus":"盘前交易","change":0.04,"latestTime":"01-14 08:06:47 EST","open":1.32,"high":1.356,"low":1.3,"amount":11908.9012077,"amplitude":0.043077,"askPrice":1.55,"askSize":200,"bidPrice":1.2,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.003723,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768401000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1254283200000,"exchange":"AMEX","adjPreClose":1.34,"postHourTrading":{"tag":"盘后","latestPrice":1.34,"preClose":1.34,"latestTime":"19:39 EST","volume":17,"amount":22.78,"timestamp":1768351140202},"volumeRatio":0.07478141590215771},"requestUrl":"/m/hq/s/CPHI","defaultTab":"news","newsList":[{"id":"1139961131","title":"惠普森医药：根据协议，Juan Zhang将把Ipragliflozin片剂及其制备方法的所有权转让给公司旗下子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1139961131","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139961131?lang=zh_cn&edition=full","pubTime":"2025-12-24 05:25","pubTimestamp":1766525134,"startTime":"0","endTime":"0","summary":"惠普森医药：根据协议，Juan Zhang将把Ipragliflozin片剂及其制备方法的所有权转让给公司旗下子公司","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CPHI"],"gpt_icon":0},{"id":"2504172423","title":"奥赛康药业1类新药利厄替尼片获批上市；强生146亿美元收购Intra-Cellular | CPHI制药在线一周药闻复盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2504172423","media":"CPHI制药在线","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504172423?lang=zh_cn&edition=full","pubTime":"2025-01-18 19:31","pubTimestamp":1737199882,"startTime":"0","endTime":"0","summary":"首先看审评审批方面，多个药获批，很值得一提的就是，奥赛康药业1类新药利厄替尼片获批上市；其次是研发方面，多个药取得重要进展，其中，全球第2款PROTAC药物BMS-986365进入Ⅲ期阶段；最后是交易及投融资方面，有不少交易尘埃落定，最大金额的是，强生146亿美元收购Intra-Cellular。该药物是首个获准用于一线治疗MCL的BTK抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118193422a226a6a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118193422a226a6a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0795875169.SGD","LU1261432733.SGD","IE00BFTCPJ56.SGD","IE00BGHQF631.EUR","IE00B4R5TH58.HKD","IE00B19Z3B42.SGD","LU1674673691.USD","IE00BJT1NW94.SGD","BK4559","LU2347655156.SGD","IE00BJJMRZ35.SGD","IE00B19Z3581.USD","LU1585245621.USD","LU1061106388.HKD","IE00B7SZLL34.SGD","LU0289739699.SGD","BK4533","LU1066051225.USD","LU1935042991.SGD","IE00B2B36J28.USD","SG9999002232.USD","LU0122379950.USD","LU0098860793.USD","LU2602419157.SGD","LU1221951129.SGD","LU1244550577.SGD","LU1929549753.HKD","IE00B42XCP33.USD","JNJ","LU1221951046.USD","IE0002270589.USD","IE00BVYPNW00.USD","IE0009355771.USD","LU0640476718.USD","IE000M9KFDE8.USD","IE00BSNM7G36.USD","CPHI","LU1914381329.SGD","LU1506573853.SGD","BK4592","LU1059921491.USD","LU0889566641.SGD","SG9999002224.SGD","LU0345770308.USD","LU1430594728.SGD","LU0203345920.USD","LU0792757196.USD","LU1066051498.USD","LU1894683348.USD","IE00B1BXHZ80.USD"],"gpt_icon":0},{"id":"2475371522","title":"科兴制药亮相CPHI Milan 2024 白蛋白紫杉醇欧盟发布仪式成功举办","url":"https://stock-news.laohu8.com/highlight/detail?id=2475371522","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475371522?lang=zh_cn&edition=full","pubTime":"2024-10-15 10:38","pubTimestamp":1728959883,"startTime":"0","endTime":"0","summary":"10月10日，全球规模较大、影响力较强的医药行业盛会——2024世界制药原料欧洲展在意大利米兰国际展览中心圆满落幕。值得一提的是，科兴制药在展会期间举办了白蛋白紫杉醇欧盟上市发布仪式，与海昶生物、欧洲市场的合作伙伴共同见证这里程碑式的一刻。据悉，该产品于今年5月获得欧盟药品GMP证书，7月底获得欧盟上市批准，并已于8月开始陆续发货。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=7BVoVRq0mso%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","CPHI","BK4007","688136"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinapharmaholdings.com","stockEarnings":[{"period":"1week","weight":0.0388},{"period":"1month","weight":-0.1377},{"period":"3month","weight":-0.2947},{"period":"6month","weight":-0.2757},{"period":"1year","weight":-0.334},{"period":"ytd","weight":0.1074}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.1933},{"period":"ytd","weight":0.0174}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"中国医药控股有限公司成立于1999年1月28日，是一家集药品研发、生产、销售为一体的现代化制药企业。公司主要从事各种高发病率和高死亡率疾病的医药产品的开发，生产和销售。目前，公司拥有多样化的产品组合，重点涵盖中枢神经类疾病、心脑血管类疾病和抗感染类疾病等治疗领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.529412,"avgChangeRate":0.158329},{"month":2,"riseRate":0.625,"avgChangeRate":0.057076},{"month":3,"riseRate":0.375,"avgChangeRate":-0.042135},{"month":4,"riseRate":0.25,"avgChangeRate":-0.067313},{"month":5,"riseRate":0.125,"avgChangeRate":-0.124434},{"month":6,"riseRate":0.5,"avgChangeRate":0.045299},{"month":7,"riseRate":0.3125,"avgChangeRate":-0.053581},{"month":8,"riseRate":0.125,"avgChangeRate":-0.112317},{"month":9,"riseRate":0.25,"avgChangeRate":-0.057874},{"month":10,"riseRate":0.529412,"avgChangeRate":0.027245},{"month":11,"riseRate":0.352941,"avgChangeRate":-0.000653},{"month":12,"riseRate":0.470588,"avgChangeRate":-0.03917}],"exchange":"AMEX","name":"惠普森医药","nameEN":"China Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"惠普森医药(CPHI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供惠普森医药(CPHI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"惠普森医药,CPHI,惠普森医药股票,惠普森医药股票老虎,惠普森医药股票老虎国际,惠普森医药行情,惠普森医药股票行情,惠普森医药股价,惠普森医药股市,惠普森医药股票价格,惠普森医药股票交易,惠普森医药股票购买,惠普森医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"惠普森医药(CPHI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供惠普森医药(CPHI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}